These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 22948809)
1. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model. Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of in vivo labeled cytotoxic T lymphocytes and cytokine-induced killer cells migration and distribution of subcutaneous gastric tumor model in nude mice]. Wu ZY; DU XH; Xu YX; Li L; Liu JC; Wang JJ; Li ZX Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):403-6. PubMed ID: 20367940 [TBL] [Abstract][Full Text] [Related]
3. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells. Kim YJ; Lim J; Kang JS; Kim HM; Lee HK; Ryu HS; Kim JY; Hong JT; Kim Y; Han SB Arch Pharm Res; 2010 Nov; 33(11):1789-95. PubMed ID: 21116782 [TBL] [Abstract][Full Text] [Related]
4. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Chan JK; Hamilton CA; Cheung MK; Karimi M; Baker J; Gall JM; Schulz S; Thorne SH; Teng NN; Contag CH; Lum LG; Negrin RS Clin Cancer Res; 2006 Mar; 12(6):1859-67. PubMed ID: 16551871 [TBL] [Abstract][Full Text] [Related]
5. Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo. Huang J; Li C; Wang Y; Lv H; Guo Y; Dai H; Wicha MS; Chang AE; Li Q Clin Immunol; 2013 Oct; 149(1):156-68. PubMed ID: 23994769 [TBL] [Abstract][Full Text] [Related]
6. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo]. Ge W; Li CH; Zhang W; Han Q; Deng WM; Chen L; You SG; Zhao CH Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):277-80. PubMed ID: 15182535 [TBL] [Abstract][Full Text] [Related]
7. Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA. Lutterbuese R; Raum T; Kischel R; Lutterbuese P; Schlereth B; Schaller E; Mangold S; Rau D; Meier P; Kiener PA; Mulgrew K; Oberst MD; Hammond SA; Baeuerle PA; Kufer P J Immunother; 2009 May; 32(4):341-52. PubMed ID: 19342971 [TBL] [Abstract][Full Text] [Related]
8. Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo. Wang J; He M; Shi W; Sha H; Feng J; Wang S; Wang Y Cancer Invest; 2009 Mar; 27(3):244-50. PubMed ID: 19194830 [TBL] [Abstract][Full Text] [Related]
9. Anti-CD3 x EGFR bispecific antibody redirects cytokine-induced killer cells to glioblastoma in vitro and in vivo. Ma P; He Q; Li W; Li X; Han H; Jin M; Liu C; Tao H; Ma J; Gao B Oncol Rep; 2015 Nov; 34(5):2567-75. PubMed ID: 26323605 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model. Kim HM; Kang JS; Lim J; Kim JY; Kim YJ; Lee SJ; Song S; Hong JT; Kim Y; Han SB Arch Pharm Res; 2009 May; 32(5):781-7. PubMed ID: 19471894 [TBL] [Abstract][Full Text] [Related]
11. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells. Ohta K; Yamaguchi Y; Shimizu K; Miyahara E; Toge T Anticancer Res; 2002; 22(5):2597-606. PubMed ID: 12529970 [TBL] [Abstract][Full Text] [Related]
12. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology. Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457 [TBL] [Abstract][Full Text] [Related]
13. [Effect of tumor antigen specific CTL induced by dendritic cells on a model of human hepatocellular carcinoma in nude mice (LCI-D20)]. Chen GL; Hu HD; Ma YJ; Li YG; Xue Q; Chen M; Ren H Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):431-4. PubMed ID: 16792867 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model. Kim HM; Lim J; Kang JS; Park SK; Lee K; Kim JY; Kim YJ; Hong JT; Kim Y; Han SB Int Immunopharmacol; 2009 Mar; 9(3):375-80. PubMed ID: 19105981 [TBL] [Abstract][Full Text] [Related]
15. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide]. Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734 [TBL] [Abstract][Full Text] [Related]
16. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro]. DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice. Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566 [TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Jiang J; Xu N; Wu C; Deng H; Lu M; Li M; Xu B; Wu J; Wang R; Xu J; Nilsson-Ehle P Anticancer Res; 2006; 26(3B):2237-42. PubMed ID: 16821594 [TBL] [Abstract][Full Text] [Related]
19. [Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells]. Shi YJ; Ren HY; Cen XN; Dong YJ; Ma MX; Zhao YL; Zhu Y; Yu JR Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):107-11. PubMed ID: 18646691 [TBL] [Abstract][Full Text] [Related]